VEGFA and metastatic colorectal cancer: Vascular endothelial growth factor (VEGF) is a major driver of tumor angiogenesis and monoclonal antibodies (mAbs) against VEGF are widely used in tumor treatment including metastatic colorectal cancer (mCRC) [1].